Structural basis for immune cell binding of Fusobacterium nucleatum via the trimeric autotransporter adhesin CbpF
Gian Luca MarongiuiD, Uwe Fink, Felix SchöpfiD, Andreas OderiD, Jens Peter von KriesiD, Daniel RodereriD
Abstract
Fusobacterium nucleatum (Fn), a commensal in the human oral cavity, is overrepresented in the colon microbiota of colorectal cancer (CRC) patients and is linked to tumor chemoresistance, metastasis, and a poor therapeutic prognosis. Fn produces numerous adhesins that mediate tumor colonization and downregulation of the hosts anti-tumor immune response. One of these, the trimeric autotransporter adhesin (TAA) CEACAM binding protein of Fusobacterium (CbpF), targets CEACAM1 on T-cells and has been associated with immune evasion of Fn-colonized tumors. Whereas the role of CEACAM1 in homophilic and heterophilic cell interactions and immune evasion is well described, the mechanistic details of its interaction with fusobacterial CbpF remain unknown due to the lack of a high-resolution structure of the adhesin-receptor complex. Here, we present two structures of CbpF alone and in complex with CEACAM1, obtained by cryogenic electron microscopy and single particle analysis. They reveal that CbpF forms a stable homotrimeric complex whose N-terminal part of the extracellular domain comprises a 64 [A] long {beta} roll domain with a unique lateral loop extension. CEACAM1 binds to this loop via its N-terminal IgV-like domain with high affinity with a nanomolar dissociation constant, as obtained by surface plasmon resonance. This study provides the first structural description of a fusobacterial TAA, illustrates a yet undescribed CEACAM1 binding mode, and paves the way for rational drug design targeting Fn in CRC.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 2.23
- Field percentile
- top 12%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis of Fusobacterium nucleatum adhesin Fap2 interaction with receptors on cancer and immune cells
Felix Schöpf, Gian Luca Marongiu, … Daniel Roderer·Nature CommunicationsPeer-reviewed·Aug 29, 2025
- Fusobacterium nucleatum host cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration
M. A. Casasanta, C. C. Yoo, … D. J. Slade·bioRxiv·Jan 15, 2020
- Clinical isolates of Fusobacterium nucleatum display strain-specific virulence and modulation by indole derivatives
Colin Scano, Ankan Choudhury, … K. Leigh Greathouse·MicrobiologyPeer-reviewed·Jul 10, 2026
- RadD from Fusobacterium nucleatum Engages NKp46 to Promote Antitumor Cytotoxicity
Ahmed Rishiq, Johanna Galaski, … Ofer Mandelboim·bioRxiv·Jul 26, 2025
- Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer
Jessica Queen, Zam Cing, … Cynthia L. Sears·npj Biofilms and MicrobiomesPeer-reviewed·May 20, 2025
- Fusobacterium nucleatum facilitates cetuximab resistance in colorectal cancer via the PI3K/AKT and JAK/STAT3 pathways
X. Yuan, H. Han, … Wan Qin, Lu Wang, Han Yin, Beibei Su, and Xianglin Yuan, Yan Li·bioRxiv·Dec 21, 2020